Elliptic Laboratories (ELABS.OL) Stock Analysis & AI Equity Report
Elliptic Laboratories (ELABS.OL) overview
Elliptic Laboratories (ELABS.OL) stock analysis and AI equity research. For the latest completed financial year, 2024, Elliptic Laboratories reported revenue of NOK 132m and operating profit of NOK 4.7m; the year-end share price was 10.48 NOK and market capitalisation was NOK 1,101m. Elliptic Laboratories is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Elliptic Laboratories's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-12-12. Data will be refreshed during report generation.
About Elliptic Laboratories
Elliptic Laboratories ASA develops software-based sensing technology for devices, using its AI Virtual Smart Sensor platform to enable functions such as proximity, presence, gesture, breathing and heartbeat detection. The company sells its solutions to smartphone, laptop, IoT and automotive markets, with a business model centered on licensed software and on-device sensing capabilities.
Generate the Elliptic Laboratories report
Elliptic Laboratories is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Elliptic Laboratories and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.